Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2125 (LINC02125)

Target
LINC02125
Molecular classification
Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2125 (LINC02125) is a human long non-coding RNA gene that produces a transcript longer than 200 nucleotides and does not encode a protein[6][1]. Like other lincRNAs, LINC02125 is transcribed from a region of the genome that does not overlap with any protein-coding gene and is classified as a long intergenic non-coding RNA[3]. LincRNAs are known to act as regulators of gene expression through diverse mechanisms including chromatin remodeling, altering genome architecture, stabilizing RNAs, regulating transcription, and interacting with protein complexes[3]. The specific biological function, disease associations, or therapeutic targeting of LINC02125 itself have not been well characterized as of 2025. There are no known drugs that target this RNA directly, and its use as a biomarker or its relevance to specific diseases remains unclear[1][6].

Other names
LINC02125
02

Mechanism of action

Not applicable (no drugs or established inhibitors/agonists documented)

03

Biological functions

Chromatin remodelingGene expression regulationTranscription regulationPotential enhancer-associated activity
04

Disease associations

Other (No direct evidence for roles in cancer, inflammation, neurodegenerative disease, cardiovascular disease, or infection as of September 2025)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2125 (LINC02125).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2125 (LINC02125).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call